DOI QR코드

DOI QR Code

Inhibitory Effects of Myagropsis myagroides Ethanol Extract on 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis-Like Skin Lesions in Mice

2,4-Dinitrochlorobenzene 유도 아토피 피부염 모델 마우스에 대한 외톨개 모자반(Myagropsis myagroides) 에탄올 추출물의 억제 효과

  • Kim, Koth-Bong-Woo-Ri (Institute of Fisheries Sciences, Pukyong National University) ;
  • Kang, Bo-Kyeong (Department of Food Science & Technology/Institute of Food Science, Pukyong National University) ;
  • Ahn, Na-Kyung (Department of Food Science & Technology/Institute of Food Science, Pukyong National University) ;
  • Choi, Yeon-Uk (Department of Food Science & Technology/Institute of Food Science, Pukyong National University) ;
  • Bae, Nan-Young (Department of Food Science & Technology/Institute of Food Science, Pukyong National University) ;
  • Park, Ji-Hye (Department of Food Science & Technology/Institute of Food Science, Pukyong National University) ;
  • Park, Sun-Hee (Department of Food Science & Technology/Institute of Food Science, Pukyong National University) ;
  • Kim, Min-Ji (Institute of Fisheries Sciences, Pukyong National University) ;
  • Ahn, Dong-Hyun (Institute of Fisheries Sciences, Pukyong National University)
  • 김꽃봉우리 (부경대학교 수산과학연구소) ;
  • 강보경 (부경대학교 식품공학과/식품연구소) ;
  • 안나경 (부경대학교 식품공학과/식품연구소) ;
  • 최연욱 (부경대학교 식품공학과/식품연구소) ;
  • 배난영 (부경대학교 식품공학과/식품연구소) ;
  • 박지혜 (부경대학교 식품공학과/식품연구소) ;
  • 박선희 (부경대학교 식품공학과/식품연구소) ;
  • 김민지 (부경대학교 수산과학연구소) ;
  • 안동현 (부경대학교 수산과학연구소)
  • Received : 2015.06.09
  • Accepted : 2015.07.20
  • Published : 2015.08.31

Abstract

This study investigated the effects of Myagropsis myagroides ethanol extract (MMEE) on 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD)-like skin lesions in BALB/c mice. The effects of MMEE on DNCB-induced BALB/c mice were evaluated by examining skin symptom severity, levels of total immunoglobulin E (IgE), tumor necrosis $factor-{\alpha}$ ($TNF-{\alpha}$), interleukin (IL)-4, and IL-10 in serum, and levels of IL-4, IL-5, IL-13, and $interferon-{\gamma}$ ($IFN-{\gamma}$) in splenocytes. MMEE significantly reduced the total clinical severity score, total IgE levels, as well as $TNF-{\alpha}$ and IL-4 production in an AD mouse model but increased IL-10 production. Production of IL-4, IL-5, and IL-13 in splenocytes was reduced by MMEE, whereas $IFN-{\gamma}$ production increased. These results suggest that MMEE can inhibit the development of AD-like skin lesions in BALB/c mice by modulating the immune response and may be an effective potential therapeutic agent for AD.

2,4-Dinitrochlorobenzene(DNCB) 유도 아토피 피부염 BALB/c 모델에서 외톨개 모자반 에탄올 추출물(MMEE)의 항아토피 효과를 알아보기 위해 육안평가, severity score, 혈청 내 total immunoglobulin E(IgE), interleukin(IL)-4, tumor necrosis $factor-{\alpha}$($TNF-{\alpha}$), IL-10 분비량 및 비장 세포 배양액 내 IL-4, IL-5, IL-13, $interferon-{\gamma}$($IFN-{\gamma}$) 분비량을 측정하였다. DNCB 반복 도포로 아토피 피부염 증상인 건조, 홍반, 짓무름 등의 증상이 두드러지게 나타남을 확인하였고, 이러한 아토피 피부염의 증상은 MMEE의 처리로 인해 증상이 감소되는 것으로 나타났다. Severity score에서도 MMEE의 처리로 인해 DNCB 단독 처리군에 비해 점수가 낮아짐을 확인하였다. 혈청에서 total IgE 및 cytokine의 분비량을 측정한 결과 total IgE, $TNF-{\alpha}$, IL-4의 분비량은 DNCB 단독 처리군에서 증가하였으나 MMEE 처리구에서 normal 군과 유사한 수준으로 감소됨을 확인하였다. 반면 IL-10의 분비량은 DNCB 단독 처리군에서는 normal 군에 비해 감소하였으나 MMEE 처리구에서는 증가하였다. 비장세포 배양액 내에서 cytokine의 분비량을 측정한 결과 IL-4, IL-13 및 IL-5의 분비량은 DNCB 단독 처리군에서는 증가하였으나 MMEE 처리구에서는 normal 군과 유사한 수준으로 감소하였으며, $IFN-{\gamma}$의 분비량은 DNCB 단독 처리군에서는 감소하였으나 MMEE 처리구에서는 증가하여 정상군과 유의적인 차이를 보이지 않았다. 따라서 MMEE는 DNCB 유도 아토피 피부염 동물 모델에서 Th1/Th2 cytokine의 활성 조절 및 total IgE 분비 억제를 통해 아토피 피부염 증상 개선에 효과를 가지는 것으로 사료된다.

Keywords

References

  1. Berke R, Singh A, Guralnick M. 2012. Atopic dermatitis: An overview. Am Fam Physician 86: 35-42.
  2. Kabashima K. 2013. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci 70: 3-11. https://doi.org/10.1016/j.jdermsci.2013.02.001
  3. Ley K. 1996. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 32: 733-742. https://doi.org/10.1016/0008-6363(96)00066-1
  4. Akdis CA, Akdis M, Trautmann A, Blaser K. 2000. Immune regulation in atopic dermatitis. Curr Opin Immunol 12: 641-646. https://doi.org/10.1016/S0952-7915(00)00156-4
  5. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. 2004. New insights into atopic dermatitis. J Clin Invest 113: 651-657. https://doi.org/10.1172/JCI21060
  6. Furue M, Terao H, Rikihisa W, Urabe K, Kinukawa N, Nose Y, Koga T. 2003. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol 48: 128-133.
  7. Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, Schachner LA, Sidbury R, Whitmore SE, Sieck CK, Van Voorhees AS. 2004. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol 50: 391-404. https://doi.org/10.1016/j.jaad.2003.08.003
  8. Jeong DH, Kim KBWR, Kim MJ, Kang BK, Bark SW, Pak WM, Kim BR, Park HM, Im MH, Ahn DH. 2014. Antiatopic activity of Sargassum micracanthum ethanol extracts. Korean J Microbiol Biotechnol 42: 82-88. https://doi.org/10.4014/kjmb.1401.01002
  9. Na HJ, Moon PD, Ko SG, Lee HJ, Jung HA, Hong SH, Seo Y, Oh JM, Lee BH, Choi BW, Kim HM. 2005. Sargassum hemiphyllum inhibits atopic allergic reaction via the regulation of inflammatory mediators. J Pharmacol Sci 97: 219-226. https://doi.org/10.1254/jphs.FP0040326
  10. Lee SY, Kim KBWR, Lim SI, Ahn DH. 2014. Antibacterial mechanism of Myagropsis myagroides extract on Listeria monocytogenes. Food Control 42: 23-28. https://doi.org/10.1016/j.foodcont.2014.01.030
  11. Jeong DH, Kim KB, Kim MJ, Kang BK, Ahn DH. 2014. Anti-inflammatory activity of methanol extract and n-hexane fraction mojabanchromanol b from Myagropsis myagroides. Life Sci 114: 12-19. https://doi.org/10.1016/j.lfs.2014.07.036
  12. Pak WM, Kim KB, Kim MJ, Cho JY, Ahn DH. 2015. Inhibitory effect of hexane fraction from Myagropsis myagroides on pancreatic ${\alpha}$-amylase in vitro. J Microbiol Biotechnol 25: 328-333. https://doi.org/10.4014/jmb.1409.09012
  13. Ahn JY, Im LR, Kim JH, Park JH, Kim DK, Lee YM. 2009. Effects of Rumecis radix water extract on development of atopic dermatitis in BALB/c mice. Kor J Pharmacogn 40:218-223.
  14. Leung DY, Hirsch RL, Schneider L, Moody C, Takaoka R, Li SH, Meyerson LA, Mariam SG, Goldstein G, Hanifin JM. 1990. Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol 85: 927-933. https://doi.org/10.1016/0091-6749(90)90079-J
  15. Zhang EY, Zhu BT. 2014. Estriol strongly inhibits DNCB-induced contact dermatitis: role of antigen-specific antibodies in pathogenesis. Endocr Connect 3: 161-172. https://doi.org/10.1530/EC-14-0080
  16. Zhang EY, Chen AY, Zhu BT. 2009. Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis. PLoS ONE 4: 1-12. https://doi.org/10.1371/journal.pone.0005361
  17. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9: 461-466. https://doi.org/10.1093/intimm/9.3.461
  18. Novak N, Bieber T, Leung DY. 2003. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 112:S128-139. https://doi.org/10.1016/j.jaci.2003.09.032
  19. Homey B, Steinhoff M, Ruzicka T, Leung DY. 2006. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118: 178-189. https://doi.org/10.1016/j.jaci.2006.03.047
  20. Choi EJ, Lee S, Kim HH, Singh TS, Choi JK, Choi HG, Suh WM, Lee SH, Kim SH. 2011. Suppression of dust mite extract and 2,4-dinitrochlorobenzene-induced atopic dermatitis by the water extract of Lindera obtusiloba. J Ethnopharmacol 137: 802-807. https://doi.org/10.1016/j.jep.2011.06.043
  21. Pate MB, Smith JK, Chi DS, Krishnaswamy G. 2010. Regulation and dysregulation of immunoglobulin E: A molecular and clinical perspective. Clin Mol Allergy 8: 3. https://doi.org/10.1186/1476-7961-8-3
  22. Niwa Y. 2000. Elevated RANTES levels in plasma or skin and decreased plasma IL-10 levels in subsets of patients with severe atopic dermatitis. Arch Dermatol 136: 125-126. https://doi.org/10.1001/archderm.136.1.125
  23. Sallusto F, Lanzavecchia A, Mackay CR. 1998. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19: 568-574. https://doi.org/10.1016/S0167-5699(98)01346-2
  24. Simon D, Braathen LR, Simon HU. 2004. Eosinophils and atopic dermatitis. Allergy 59: 561-570. https://doi.org/10.1111/j.1398-9995.2004.00476.x
  25. Leung DY, Bieber T. 2003. Atopic dermatitis. Lancet 361:151-160. https://doi.org/10.1016/S0140-6736(03)12193-9
  26. Yang G, Lee K, Lee MH, Kim SH, Ham IH, Choi HY. 2011. Inhibitory effects of Chelidonium majus extract on atopic dermatitis-like skin lesions in NC/Nga mice. J Ethnopharmacol 138: 398-403. https://doi.org/10.1016/j.jep.2011.09.028
  27. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA. 2009. Atopic dermatitis: A disease caused by innate immune defects? J Invest Dermatol 129: 14-30. https://doi.org/10.1038/jid.2008.259

Cited by

  1. Inhibitory Activity of Sargassum hemiphyllum Ethanol Extract on Inflammatory Response in LPS-induced RAW 264.7 Cells and Mouse Model vol.32, pp.4, 2017, https://doi.org/10.7841/ksbbj.2017.32.4.319
  2. Anti-inflammatory Effects of Sargachromanol I, Sargachromanol G, and Saringosterol from Hexane Fraction of Myagropsis myagroides vol.25, pp.1, 2015, https://doi.org/10.1007/s12257-019-0277-1
  3. Inhibition of nitric oxide and lipid accumulation by Sargassum sp. seaweeds and their antioxidant properties vol.28, pp.2, 2021, https://doi.org/10.11002/kjfp.2021.28.2.288